S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

APYX Apyx Medical Corporation

1.34

0.00 (0.00%)

Pre Market

Last Updated: 03:16:45

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Apyx Medical (NASDAQ:APYX)
Historical Stock Chart
From Jun 2024 to Jul 2024

Click Here for more Apyx Medical Charts.

Apyx Medical (NASDAQ:APYX)
Historical Stock Chart
From Jul 2023 to Jul 2024

Click Here for more Apyx Medical Charts.

Apyx Medical Corporation News

Apyx Medical Corporation Launches the "Renewing Lives" Give-Back Campaign Providing Treatments with Renuvion to Benefit Physical Appearance and Mental Health
Wednesday 26 June 2024 (5 days ago) • PR Newswire (US)

Form SD - Specialized disclosure report
Friday 31 May 2024 (1 month ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 9 May 2024 (2 months ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Thursday 9 May 2024 (2 months ago) • Edgar (US Regulatory)

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Thursday 9 May 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 9 May 2024 (2 months ago) • Edgar (US Regulatory)

Apyx Medical Corporation Reports First Quarter 2024 Financial Results; Reaffirms Full Year 2024 Financial Outlook
Thursday 9 May 2024 (2 months ago) • Business Wire

Form 8-K - Current report
Thursday 9 May 2024 (2 months ago) • Edgar (US Regulatory)

Apyx Medical Corporation Announces Board Leadership Transition
Thursday 9 May 2024 (2 months ago) • Business Wire

Apyx Medical Corporation to Release First Quarter of Fiscal Year 2024 Financial Results on May 9, 2024
Thursday 25 April 2024 (2 months ago) • Business Wire

Apyx Medical Corporation Showcases New Data and Treatment Insights at the Renuvion® Users’ Summit
Thursday 11 April 2024 (3 months ago) • Business Wire

Apyx Medical Corporation Reports Fourth Quarter and Full Year 2023 Financial Results; Introduces Full Year 2024 Financial Outlook
Thursday 21 March 2024 (3 months ago) • Business Wire

More Apyx Medical Corporation News Articles

Ethema Health (PK)

Fannie Mae (QB)

Northwest Biotherapeutics (QB)

Digital Brand Media and ... (PK)

Virexit Technologies (PK)

Brookmount Explorations (PK)

Anavex Life Sciences

RespireRx Pharmaceuticals (PK)

Lightwave Logic

Rennova Health (PK)

Kraig Biocraft Laborator... (QB)

Elite Pharmaceuticals (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions